These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2040690)

  • 1. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.
    Chatterjee VK; Nagaya T; Madison LD; Datta S; Rentoumis A; Jameson JL
    J Clin Invest; 1991 Jun; 87(6):1977-84. PubMed ID: 2040690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
    Piedrafita FJ; Ortiz MA; Pfahl M
    Mol Endocrinol; 1995 Nov; 9(11):1533-48. PubMed ID: 8584031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone resistance syndrome: correlation of dominant negative activity and location of mutations.
    Nagaya T; Eberhardt NL; Jameson JL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):982-90. PubMed ID: 8408475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal variants of thyroid hormone receptor beta: differential function and potential contribution to syndrome of resistance to thyroid hormone.
    Ng L; Forrest D; Haugen BR; Wood WM; Curran T
    Mol Endocrinol; 1995 Sep; 9(9):1202-13. PubMed ID: 7491112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific.
    Zavacki AM; Harney JW; Brent GA; Larsen PR
    Mol Endocrinol; 1993 Oct; 7(10):1319-30. PubMed ID: 8264663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.
    Yagi H; Pohlenz J; Hayashi Y; Sakurai A; Refetoff S
    J Clin Endocrinol Metab; 1997 May; 82(5):1608-14. PubMed ID: 9141558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
    Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
    Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
    Tagami T; Jameson JL
    Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable transcriptional activity and ligand binding of mutant beta 1 3,5,3'-triiodothyronine receptors from four families with generalized resistance to thyroid hormone.
    Meier CA; Dickstein BM; Ashizawa K; McClaskey JH; Muchmore P; Ransom SC; Menke JB; Hao EH; Usala SJ; Bercu BB
    Mol Endocrinol; 1992 Feb; 6(2):248-58. PubMed ID: 1569968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.
    Usala SJ; Menke JB; Watson TL; Wondisford FE; Weintraub BD; Bérard J; Bradley WE; Ono S; Mueller OT; Bercu BB
    Mol Endocrinol; 1991 Mar; 5(3):327-35. PubMed ID: 1653889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
    Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
    Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.
    Ulisse S; Esslemont G; Baker BS; Krishna V; Chatterjee K; Tata JR
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1205-9. PubMed ID: 8577741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent dimerization properties of mutant beta 1 thyroid hormone receptors are associated with different dominant negative activities.
    Hao E; Menke JB; Smith AM; Jones C; Geffner ME; Hershman JM; Wuerth JP; Samuels HH; Ways DK; Usala SJ
    Mol Endocrinol; 1994 Jul; 8(7):841-51. PubMed ID: 7984146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
    Takeda T; Suzuki S; Liu RT; DeGroot LJ
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
    Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
    Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional properties of a novel mutant thyroid hormone receptor in a family with generalized thyroid hormone resistance syndrome.
    Adams M; Nagaya T; Tone Y; Jameson JL; Chatterjee VK
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):281-9. PubMed ID: 1563081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant negative and DNA-binding properties of mutant thyroid hormone receptors that are defective in homodimerization but not heterodimerization.
    Kitajima K; Nagaya T; Jameson JL
    Thyroid; 1995 Oct; 5(5):343-53. PubMed ID: 8563470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
    Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
    Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
    Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
    J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative and positive transcriptional regulation by thyroid hormone receptor isoforms.
    Rentoumis A; Chatterjee VK; Madison LD; Datta S; Gallagher GD; Degroot LJ; Jameson JL
    Mol Endocrinol; 1990 Oct; 4(10):1522-31. PubMed ID: 2284000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.